Top Markets
Coin of the day
Diagnocure, Inc. Diagnocure, Inc.

Diagnocure, Inc.

DGCRF
Rang in Aktien #41418
Diagnocure, Inc. is a Canadian life sciences company dedicated to developing... Diagnocure, Inc. is a Canadian life sciences company dedicated to developing and commercializing innovative products for cancer diagnosis. Its core business revolves around advanced molecular diagnostic tests designed for the identification and management of cancerous conditions. The company's portfolio includes the PCA3 test for prostate cancer diagnosis, as well as the Guanylyl Cyclase C (GCC) marker and the Previstage GCC colorectal cancer staging test, both vital for patients with colorectal cancer. They also offer PCP, a multi-marker diagnostic for prostate cancer. In addition to these tests, Diagnocure provides specialized services such as gene expression and copy number variation analysis, mutation detection, SNP genotyping, and comprehensive platform and laboratory environmental support. Established in 1994 as 9342-8530 Québec Inc. and previously known as DiagnoCure Inc., the company is headquartered in Quebec, Canada.
Aktienkurs
$0.0001
Zuletzt synchronisiert: 2025-06-11
Marktkapitalisierung
$21.52K
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
0.00%
Land
CA
Handel Diagnocure, Inc. (DGCRF)

Kategorie

Aktien-Split-Historie für Diagnocure, Inc. (DGCRF)
Die Aktie Diagnocure, Inc. (Symbol: DGCRF) durchlief insgesamt 0 Aktiensplits.
Der letzte Aktiensplit fand am Aug 13, 2026 statt.
Eine DGCRF-Aktie, die vor dem Aug 13, 2026 gekauft wurde, entspricht heute 0 DGCRF-Aktien.
Liste der Aktiensplits
Jahr Aktien-Split Multiplikator Kumulierter Multiplikator
Nicht genügend Daten für die angegebenen Daten.
Aktiensplits ähnlicher Unternehmen oder Wettbewerber
Unternehmen Anzahl der Aktiensplits Kumulierter Multiplikator Land
2 x4
IE
0 -
CN
0 -
CH
0 -
CH
0 -
CN